DRRX Overview
Upcoming Projects (DRRX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DRRX)
-
A Second View: Discussing Larsucosterol (DUR-928) in Alcoholic Hepatitis and the AHFIRM trial
Ticker: DRRX
Executed On: Feb 23, 2023 at 03:00 PM EST -
A discussion of Larsucosterol (DUR-928) in Alcoholic Hepatitis and the AHFIRM trial
Ticker: DRRX
Executed On: Feb 01, 2023 at 10:00 AM EST
Upcoming & Overdue Catalysts (DRRX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (DRRX)
-
Outcome of FDA Advisory Committee Meeting regarding Durect's (DRRX) POSIMIR: 6/12 Support Approval
Ticker: DRRX
Occurred on: Jan 17, 2020 -
Phase 2 preliminary data of Durect's(DRRX) DUR-928 in Alcoholic hepatitis (AH) due May 7, 2019
Ticker: DRRX
Occurred on: May 07, 2019 -
REMOXY PDUFA Date of September 25, 2016
Tickers: DRRX, PTIE
Occurred on: Sep 26, 2016 -
DURECT Announces FDA Advisory Committee Meeting for REMOXY
Ticker: DRRX
Occurred on: May 19, 2016 -
DURECT Announces FDA Acceptance of REMOXY NDA
Tickers: DRRX, PTIE
Occurred on: Apr 12, 2016 -
DURECT Announces Resubmission of REMOXY New Drug Application to the U.S. Food and Drug Administration
Tickers: DRRX, PTIE
Occurred on: Mar 29, 2016 -
NDA of Remoxy (oxycodone) Extended-Release Capsules CII expected to be refiled 1Q 2016
Ticker: DRRX
Occurred on: Mar 29, 2016
Strategic Initiatives (DRRX)
-
DURECT (DRRX) and Gilead (GILD) Enter into License Agreement for Long-Acting Injectable HIV Investigational Product
Tickers: DRRX, GILD
Announcement Date: Jul 22, 2019
